Controlled dangerous substances; requiring registration of pain management clinics; stating requirements for clinics; providing penalties. Effective date.
Impact
The bill aims to improve the oversight of pain management clinics, especially in the context of addressing opioid prescriptions and potential drug diversion. By instituting a registration process, the bill seeks to filter out clinics operated by individuals with previous violations in their prescribing practices and to hold clinics accountable for strict adherence to operational standards. It is expected to enhance regulation and monitoring of these facilities to mitigate risks associated with the prescription of controlled dangerous substances.
Summary
Senate Bill 573 establishes requirements for pain management clinics in Oklahoma by mandating their registration with the Oklahoma State Bureau of Narcotics and Dangerous Drugs Control. It defines a pain management clinic and delineates the stipulations under which these clinics must operate. This includes the responsibilities of both the designated administrators and licensed prescribers within the clinics, as well as general operational requirements including infection control and quality assurance practices meant to ensure patient safety and compliance with state laws.
Contention
Points of contention have arisen regarding the implications of the registration process and the potential for increased barriers to access for patients requiring pain management. Opponents of the bill may argue that stringent regulations could limit available care options for those in chronic pain or that increased administrative demands might overburden clinics that are already providing legitimate services. Proponents, on the other hand, argue that such regulations are necessary to combat opioid misuse and provide safer pain management solutions.
Controlled dangerous substances; requiring pain management clinics to register with State Board of Medical Licensure and Supervision; prohibiting the dispensation of controlled dangerous substances at pain management clinics; codification; effective date.
Controlled dangerous substances; authorizing certain scientific research and clinical trials related to psilocybin and psilocyn; requiring registration; providing certain immunities; effective date.
Controlled dangerous substances; requiring Oklahoma State Bureau of Narcotics and Dangerous Drugs Control to establish certain procedures relating to central repository. Effective date.
Controlled dangerous substances; providing for registration and regulation of pain management clinics; prohibiting dispensation of controlled dangers substances at pain management clinics. Effective date.
Controlled dangerous substances; directing creation of certain task forces; authorizing and requiring certain boards to take certain actions; adding certain violation. Effective date.